CN101612251B

CN101612251B - Traditional Chinese medicine for treating primary liver cancer

Info

Publication number: CN101612251B
Application number: CN200910101272XA
Authority: CN
Inventors: 沈信堂
Original assignee: Individual
Current assignee: Individual
Priority date: 2009-07-27
Filing date: 2009-07-27
Publication date: 2011-08-31
Anticipated expiration: 2029-07-27
Also published as: CN101612251A

Abstract

The invention discloses a traditional Chinese medicine for treating primary liver cancer. The traditional Chinese medicine comprises the following raw materials proportioning by weight: 20 to 30 parts of oldenlandia diffusa, 20 to 30 parts of lobelia, 20 to 30 parts of agrimonia pilosa, 20 to 30 parts of herba scutellariae barbatae, 10 to 20 parts of morel, 2 to 4 parts of aweto, 8 to 15 parts of flos buddlejae and 10 to 20 parts of glossy privet fruit, which are added with water and decocted into decoction. For a patient with liver ascites, 20 to 30 parts of herba rostellulariae and 10 to 15 parts of areca are added. The traditional Chinese medicine has the advantages of protecting the liver, promoting liver cell regeneration, expanding the blood vessel of the liver, reinforcing the blood circulation in the liver and increasing the blood flow of the liver, thereby improving liver nutrition and oxygen supply and reinforcing the immunological function. The sources of all the medicinal materials are extensive, the medicinal materials can be mostly collected in southern regions, various Chinese herbal medicines are adopted to carry out comprehensive treatment with obvious effect and convenient taking, each prescription composition conforms to the prescription of medicine politics, the synthetic action of each medicine is utilized to treat the liver cancer, so that the traditional Chinese medicine has no toxic or side effect on a human body.

Description

Control the Chinese medicine of primary hepatocarcinoma

Technical field

The invention belongs to Chinese medicine, more specifically to the Chinese medicine of the treatment property sent out hepatocarcinoma.

Background technology

Primary hepatocarcinoma (primary carcinoma of the liver) is one of China's common cancer.The mortality rate height is only second to stomach, esophagus and occupies the 3rd in the dead cis-position of malignant tumor, partly then accounting for second in the geographic rural area, is only second to gastric cancer.China dies from about 110,000 people of hepatocarcinoma every year, accounts for 45% of whole world PLC mortality number.The primary hepatocarcinoma onset is often hidden, and how uses AFP in hepatopathy is followed up a case by regular visits to or in the health check-up generaI investigation and super inspection of Type B chances on hepatocarcinoma, and its course of disease of prescription on individual diagnosis person has entered middle and advanced stage mostly in case symptom occurs.At present generally for the early stage employing excision of hepatocarcinoma, can not the first-selected transcatheter hepatic arterial chemoembolization (TAE) of excision person, the anhydrous alcohol intratumor injection; The ligation of big hepatocarcinoma employing in mid-term hepatic artery catheterization is that main multi-mode treatment or transcatheter hepatic arterial chemoembolization treated to consider excision again after tumor is dwindled; Mid and late liver cancer then Chinese herbal medicine is that main Chinese and western medicine Comprehensive Treatment is to improve symptom, to prolong life cycle.But adopt the general effect of Chinese herbal treatment relatively poor, survival rate is low.

Summary of the invention

The purpose of this invention is to provide a kind of good effect, the Chinese medicine of controlling primary hepatocarcinoma that survival rate is high.

The Chinese medicine of controlling primary hepatocarcinoma of the present invention is characterized in that it is to decoct with water into decoction with the following weight proportion raw material: Herba Hedyotidis Diffusae 20-30 part, Herba Lobeliae Chinensis 20-30 part, Herba Agrimoniae 20-30 part, Herba Scutellariae Barbatae 20-30 part, Herba Solani Nigri 10-20 part, Cordyceps 2-4 part, Flos Buddlejae 8-15 part and Fructus Ligustri Lucidi 10-20 part.Add Herba Rostellulariae 20-30 part and Semen Arecae 10-15 part again for what hepatic ascites arranged.According to decocting with water into decoction 1 dose of above-mentioned prescription every day, divide and take for 2-3 time.

The invention has the beneficial effects as follows: it has the liver protecting, promotes liver cell regeneration, with the expansion liver vessel, strengthens the circulation of liver inner blood and increases the liver blood flow amount, thereby improve liver nutrition and oxygen supply, raise immunity.All crude drug sources are extensive, and south one is with big multipotency to collect, and adopt multiple Chinese herbal medicine Comprehensive Treatment, effect obvious, and taking convenience, each prescription are formed and met the pharmaceutical control and administration regulation, utilize the comprehensive function treatment hepatocarcinoma of the medicine of respectively distinguishing the flavor of, and human body is had no side effect.Herba Hedyotidis Diffusae among the present invention, Herba Lobeliae Chinensis, Herba Agrimoniae, Herba Scutellariae Barbatae, the main effect of Herba Solani Nigri are blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, can obviously reduce the serum soluble interleukin II acceptor levels of liver cancer patient, CD3 and CD4/CD8 ratio simultaneously raise, by suppressing the phosphodiesterase activity of surface of cell membrane, improve intracellular CAMP level, regulating cell propagation and differentiation improve macrophage and NK cell activity, increase T3, T4 level.But Cordyceps strengthening the body resistance inducing cancer cell produces a large amount of lysosomes, causes its dissolving degeneration necrosis, the activated lymphocyte hypertrophy.Flos Buddlejae, the gentle cloudy nourishing the liver of Fructus Ligustri Lucidi.The Herba Rostellulariae heat-clearing and toxic substances removing, inducing diuresis to remove edema; The Semen Arecae removing mass, the therapeutic method to keep the adverse QI flowing downwards, row water can effectively improve retention water liquid and move and metabolism in body, effectively stops growing once more of new unboiled water liquid, alleviates the hepatic ascites symptom.The medication process is to take 2-3 time every day, each consumption 250-300ml.With medicine of the present invention at clinical treatment 8 routine primary hepatocarcinoma, age 45-76 year, 2 of women, wherein the I phase is 1 example, the II phase be 5 examples, the III phase be 2 examples, 128 days 1 examples of the shortest existence after controlling, 4 examples of survival 1-2,2 examples of survival 2-4,1 example of survival more than 4 years can improve survival rate preferably.

The specific embodiment

The invention will be further described below in conjunction with embodiment.

Material name	Embodiment 1	Embodiment 2	Embodiment 3	Embodiment 4	Embodiment 5
						Herba Hedyotidis Diffusae	20 parts	30 parts	25 parts	25 parts	28 parts
Herba Lobeliae Chinensis	30 parts	20 parts	25 parts	28 parts	25 parts
						Herba Agrimoniae	25 parts	30 parts	20 parts	25 parts	20 parts
Herba Scutellariae Barbatae	30 parts	25 parts	20 parts	28 parts	25 parts
						Herba Solani Nigri	10 parts	12 parts	20 parts	18 parts	15 parts
Cordyceps	2 parts	3 parts	4 parts	3 parts	2 parts
						Flos Buddlejae	8 parts	10 parts	12 parts	15 parts	10 parts
Fructus Ligustri Lucidi	10 parts	12 parts	15 parts	18 parts	20 parts
						Herba Rostellulariae	20 parts	25 parts	30 parts
Semen Arecae	10 parts	15 parts	12 parts

According to 1 dose of above-mentioned prescription every day, add water and decoct into decoction with conventional method, divide and take for 2-3 time, wherein embodiment 1-3 has the patient of hepatic ascites to take.Because Cordyceps costs an arm and a leg, take after can decocting into decoction separately.

Claims

1. control the Chinese medicine of primary hepatocarcinoma, it is characterized in that it is to decoct with water into decoction with the following weight proportion raw material: Herba Hedyotidis Diffusae 20-30 part, Herba Lobeliae Chinensis 20-30 part, Herba Agrimoniae 20-30 part, Herba Scutellariae Barbatae 20-30 part, Herba Solani Nigri 10-20 part, Cordyceps 2-4 part, Flos Buddlejae 8-15 part and Fructus Ligustri Lucidi 10-20 part.

2. control the Chinese medicine of primary hepatocarcinoma, it is characterized in that it is to decoct with water into decoction with the following weight proportion raw material: Herba Hedyotidis Diffusae 20-30 part, Herba Lobeliae Chinensis 20-30 part, Herba Agrimoniae 20-30 part, Herba Scutellariae Barbatae 20-30 part, Herba Solani Nigri 10-20 part, Cordyceps 2-4 part, Flos Buddlejae 8-15 part, Fructus Ligustri Lucidi 10-20 part, Herba Rostellulariae 20-30 part and Semen Arecae 10-15 part.